Blog

The future of drug pricing policies in the United States depends on the outcome of the 2024 elections, with Democratic and Republican candidates presenting distinct approaches. Vice President Kamala Harris aims to expand the Biden administration's existing policies, while former President Donald Trump's position remains less defined. Harris has pledged to broaden the scope of Medicare drug price negotiations, a key achievement of the Biden presidency, to include more drugs and benefit a broader population. It intends to use the resulting savings to fund an ambitious new proposal to cover long-term home care under Medicare. That means a commitment to…

In response to the destructive aftermath of Hurricane Helene, U.S. authorities initiated emergency airlifts of intravenous (IV) fluids from international manufacturers to mitigate a critical shortage that led hospitals to postpone surgeries and prioritize critical patients. The crisis was exacerbated by extensive flooding in western North Carolina, which severely impacted a key Baxter plant responsible for producing approximately 60 percent of the IV fluids distributed across the country. These fluids are essential for a wide range of medical applications, including home dialysis, neonatal intensive care, and adults requiring nutritional support through tube feeding. The damage to the Baxter facility required…